Guided Therapeutics reveals details of $50m LuViva
Post# of 117
"In the 3 years following CFDA approval, SMI must sell at least 3,500 devices – 500 in the 1st year, 1,000 in the 2nd and 2,000 in the 3rd
– and buy at least 25.2 million controlled programmable chips from Guided Therapeutics. All told, Guided Therapeutics said it expects to bring in $47.9 million from the deal over 3 years."
https://www.massdevice.com/guided-therapeutic...eal-china/
Guided Therapeutics Re-establishes Communications with U.S. FDA
and Discusses Plan for Refiling for Approval of the LuViva® Advanced Cervical Scan
Press Release | 07/18/2017
https://www.otcmarkets.com/stock/GTHP/news/Gu...?id=164818
CEO: Gene Cartwright
Recruited to Guided Therapeutics in January, 2014
24 years at Abbott Diagnostics
Over 30 years of experience working in the IVD diagnostics industry
GM of Hematology business
GM of Molecular Diagnostics business
VP of Marketing for Diagnostics ($3B) for 5 years
Recruited to GE as President Molecular Diagnostics
Spun out GE JV (Omnyx, LLC), Founder and CEO for 5 years
PhD in Chemistry Stanford, MBA Northwestern
Guided Therapeutics, Inc. (GTHP) Stock Research Links
Never argue with stupid people, they will drag you down to their level and then beat you with experience.
Get .... PrivacyLok https://cyberidguard.com/
Try SafeVchat: https://cyberidguard.com/
My comments are only my opinion and are not to be used for investment advice.
Please conduct your own due diligence before choosing to buy or sell any stock.